Lillys Mounjaro (Tirzepatide), a GIP/GLP-1 Dual Agonist, Demonstrated Cardiovascular Protection in Landmark Head-to-Head Trial, Reinforcing Its Benefit in Patients with Type 2 Diabetes and Heart Disease (Eli Lilly and Company, accessed 19 August 2025)
10.1210/en.2009-1272 [DOI] [PubMed] [Google Scholar] 89.Bosco D, Armanet M, Morel P, Niclauss N, Sgroi A, Muller YD, et al
These include persistent dizziness, reduced urine output, dark-coloured urine, muscle cramps, or confusion
This is exactly why we include vitamin C in our detox drips
Semaglutide is classified as FDA Pregnancy Category: Not Assigned under the current labeling system (the previous letter category system was phased out)
Stronger, more functional tissue in as little as 14 days in animal models